Cover Image
市場調查報告書

美國的藥物濫用檢測市場:醫院,民間檢驗所,緊急治療室(ER),門診病人診療中心

US Drugs of Abuse Testing Market Forecast 2017-2021: Hospitals, Commercial Laboratories, POC Locations

出版商 Venture Planning Group 商品編碼 305193
出版日期 內容資訊 英文 278 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的藥物濫用檢測市場:醫院,民間檢驗所,緊急治療室(ER),門診病人診療中心 US Drugs of Abuse Testing Market Forecast 2017-2021: Hospitals, Commercial Laboratories, POC Locations
出版日期: 2017年12月12日 內容資訊: 英文 278 Pages
簡介

本報告提供美國的藥物濫用檢測市場相關調查分析,提供新興檢驗,技術,檢查裝置驗證,以及主要供應商的銷售額預測,市場佔有率,策略性簡介等相關的系統性資訊。

市場與技術概要

  • 主要的藥物濫用
    • 概要
    • 檢驗方法
    • 安非他命
    • 巴比妥酸鹽藥
    • 苯二氮平類
    • 大麻/印度大麻
    • 古柯鹼
    • LSD
    • 美沙酮
    • 安眠酮
    • 鴉片劑
    • 天使塵PCP
    • 三環抗憂鬱藥物(TCA)
  • 檢查裝置檢討
  • 主要的體外診斷技術與其潛在用途
    • 單株抗體·多株抗體
    • 免疫測量
    • 串聯式質譜分析
    • IT·自動化
    • 乾式化學分析
    • 生物感應器

美國

  • 摘要整理
  • 商務環境
  • 市場結構
  • 分權化檢驗的理論的根據
  • 市場規模·成長率,主要供應商的銷售額與市場佔有率

替代性的市場普及策略

  • 內部開發
  • 合資企業協定
  • 與大學的契約
  • 流通策略
    • 行銷的方法
    • 產品的複雜性
    • 客戶的偏好
    • 既有廠商
    • 新加入廠商
    • 經銷商的類型
    • 市場區隔要素

加入市場的潛在障礙與風險

  • 市場成熟度
  • 成本控制
  • 競爭
  • 技術方面的優勢與限制
  • 專利保護
  • 法規限制
  • 分散式檢查市場課題

競爭策略

  • Abbott Laboratories
  • AdnaGen
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • DiaSorin
  • 榮研化學
  • FUJIREBIO/Innogenetics
  • Instrumentation Laboratory
  • 協和MEDEX株式會社
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • 和光純藥工業
  • Wallac/PE

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: VPCC24756

This new 278-page report from VPGMarketResearch provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene.

During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

This report is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.

Contains 278 pages and 20 tables

Table of Contents

Introduction

Market and Technology Overview

  • A. Major Drugs of Abuse
    • 1. Overview
    • 2. Test Methodologies
    • 3. Amphetamines
    • 4. Barbiturates
    • 5. Benzodiazepines
    • 6. Cannabinoids/Marijuana
    • 7. Cocaine
    • 8. Lysergic Acid Diethylamide (LSD)
    • 9. Methadone
    • 10. Methaqualone
    • 11. Opiates
    • 12. Phencyclidine
    • 13. Tricyclic Antidepressants
  • B. Instrumentation Review
  • C. Major In Vitro Diagnostic Technologies And Their Potential Applications
    • 1. Monoclonal and Polyclonal Antibodies
    • 2. Immunoassays
      • a. Technological Principle
      • d. Chemiluminescence
      • c. Enzyme Immunoassays (EIA)
        • Overview
        • ELISA
        • EMIT
        • Electrochemical
      • d. Radioimmunoassays (RIA)
      • e. Immunoprecipitation
      • f. Affinity Chromatography
    • 3. Tandem Mass Spec
    • 4. IT and Automation
    • 5. Dry Chemistry
    • 6. Biosensors

U.S.A.

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Rationale for Testing Decentralization
    • 1. Overview
    • 2. Regulatory Trends
    • 3. Economic Trends
    • 4. Demographic Trends
    • 5. Technological Trends
    • 6. Social Trends
    • 7. Quality of Care
    • 8. Defensive Medicine
    • 9. Quality Control Issues
  • E. Market Size, Growth and Major Instrument and Reagent Suppliers' Sales and Market Shares

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints

G. Decentralized Testing Market Challenges

Competitive Strategies

  • Abbott Laboratories
  • AdnaGen
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken
  • Fujirebio/Innogenetics
  • Grifols
  • Instrumentation Laboratory
  • Kyowa Medex
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako
  • Wallac/PE

List of Tables

  • Major Companies Developing or Marketing Drugs of Abuse Tests
  • U.S.A., Drugs of Abuse Test Volume Forecast By Market Segment
  • U.S.A., All Market Segments, Drugs of Abuse Test Volume Forecast by Assay
  • U.S.A., Hospital Laboratories, Drugs of Abuse Test Volume Forecast by Assay
  • U.S.A., Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by Assay
  • U.S.A., Physician Offices/Group Practices, Drugs of Abuse Test Volume Forecast by Assay
  • U.S.A., Drugs of Abuse Reagent Market Forecast By Market Segment by Assay
  • U.S.A., All Market Segments, Drugs of Abuse Reagent Market Forecast by Assay
  • U.S.A., Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
  • U.S.A., Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
  • U.S.A., Physician Offices/Group Practices, Drugs of Abuse Reagent Market Forecast by Assay
  • U.S.A., Ancillary Hospital Locations Estimated Number
  • U.S.A., Ancillary Hospital Locations Annual Utilization
  • U.S.A., Hospital Emergency Departments Drugs of Abuse Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Drugs of Abuse Reagent and Instrument Sales Forecast
  • U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
  • U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
  • U.S.A., Ambulatory Care Centers Drugs of Abuse Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Drugs of Abuse Reagent and Instrument Sales Forecast
  • U.S.A., Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
Back to Top